ITW
64
2
PSA
56
5
AA
47
4
PNR
69
6
TRV
48
2
AAP
30
3
BAX
41
3
JPM
59
3
FLR
60
4
EMR
62
14
IPG
50
2
MU
39
5
ROP
53
2
CMA
53
3
CME
56
3
WY
53
2
PFE
21
-2
CTAS
53
3
CINF
40
5
SRE
52
2
ITW
64
2
PSA
56
5
AA
47
4
PNR
69
6
TRV
48
2
AAP
30
3
BAX
41
3
JPM
59
3
FLR
60
4
EMR
62
14
IPG
50
2
MU
39
5
ROP
53
2
CMA
53
3
CME
56
3
WY
53
2
PFE
21
-2
CTAS
53
3
CINF
40
5
SRE
52
2
Financhill
Back

MakeMyTrip 10K Form

Buy
75

MMYT
MakeMyTrip

Last Price:
102.21
Seasonality Move:
10.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MMYT News And Ratings

See the #1 stock for the next 7 days that we like better than MMYT

MMYT Financial Statistics

Sales & Book Value

Annual Sales: $782.52M
Cash Flow: $35.64M
Price / Cash Flow: 68.07
Annual Sales: $10.62
Price / Book: 9.63

Profitability

EPS (TTM): 1.83000
Net Income (TTM): $235.16M
Gross Margin: $567.44M
Return on Equity: 22.25%
Return on Assets: 14.4%

MakeMyTrip Earnings Forecast

Key MakeMyTrip Financial Ratios

  • The Gross Profit Margin over the past 17 years for MMYT is 72.51%.
  • The Selling, General & Administrative Expenses for MMYT have been equal to 41.23% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 8.19% of Operating Income.
  • The Net Earning history of MMYT is 27.71% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 12 years.

MakeMyTrip Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Hotels, Restaurants & Leisure
Sector: Consumer Discretionary
Current Symbol: MMYT
CUSIP: V5633W
Website: makemytrip.com

Debt

Debt-to-Equity Ratio: 0.2
Current Ratio: 2.82
Quick Ratio: 2.42

Price-to-Earnings

Trailing P/E Ratio: 58.77
Forward P/E Ratio: 53.54

MMYT Technical Analysis vs Fundamental Analysis

Buy
75
MakeMyTrip (MMYT) is a Buy

Is MakeMyTrip a Buy or a Sell?

  • MakeMyTrip stock is rated a Buy
    The current MakeMyTrip [MMYT] share price is $102.26. The Score for MMYT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.